Skip to main content
INMD
NASDAQ Industrial Applications And Services

InMode Discloses Rejected Sale Offers, Seeks Shareholder Approval for Special Committee Compensation

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$13.36
Mkt Cap
$846.473M
52W Low
$12.72
52W High
$16.74
52W Position info
5.0% above low
Off High info
20% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

INMD is trading near its 52-week low of $12.72 (5.0% above the low).

Summary

InMode announced its Annual General Meeting, revealing that a Special Committee previously explored and rejected potential sale offers, deeming them inadequate. Shareholders will vote on routine matters, director RSU grants, and the compensation for this Special Committee.


Key Events · Corporate Governance and Compliance · INMD

  • Special Committee Rejected Sale Offers

    A Special Committee, formed in November 2025 to evaluate a potential company sale, concluded in February 2026 that all proposals received were inadequate and not in the best interest of shareholders, leading to the termination of the sale process.

  • Shareholder Vote on Committee Compensation

    Shareholders will vote to approve compensation for the Special Committee members, totaling NIS 643,080 (approximately $173,800 USD), which exceeded the company's compensation policy limits and requires shareholder approval.

  • Routine Director Re-election and Auditor Re-appointment

    Shareholders will vote on the re-election of Dr. Hadar Ron as a Class I director and the re-appointment of PricewaterhouseCoopers (PwC) as the independent auditors for the fiscal year 2026.

  • Director RSU Grants

    Approval is sought for a total of 6,000 restricted share units (RSUs) to three non-executive directors (Dr. Shlomo Nass, Dr. Hadar Ron, and Mr. Nadav Kenneth), with vesting scheduled for February 2027 and February 2028.


Analysis · INMD · Industrial Applications And Services

This 6-K announces InMode's Annual General Meeting and its proposals. The most significant disclosure is that a Special Committee of the Board was formed in November 2025 to evaluate a potential sale of the company. The committee, with external advisors, concluded in February 2026 that all received proposals did not reflect adequate value and decided not to proceed with a sale. This reveals a past strategic exploration and the board's confidence in the company's long-term value, as they rejected offers. Shareholder approval is now sought for the committee's compensation, which exceeded the company's compensation policy limits.

At the time of this filing, INMD was trading at $13.36 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $846.5M. The 52-week trading range was $12.72 to $16.74. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

INMD - Latest Insights

INMD
Jul 20, 2026, 4:01 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $15.36
Real-time Price: $15.14 info
Change: -$0.220 (-1%) info
Market Cap: $870.259M info
INMD
Jul 20, 2026, 7:21 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $15.31
Real-time Price: $15.14 info
Change: -$0.170 (-1%) info
Market Cap: $870.259M info
INMD
Jul 16, 2026, 5:51 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $15.50
Real-time Price: $15.14 info
Change: -$0.360 (-2%) info
Market Cap: $870.259M info
INMD
Jul 13, 2026, 9:00 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $15.20
Real-time Price: $15.14 info
Change: -$0.060 (-0.39%) info
Market Cap: $870.259M info
INMD
Jul 13, 2026, 7:00 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $15.20
Real-time Price: $15.14 info
Change: -$0.060 (-0.39%) info
Market Cap: $870.259M info